AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9408935 — intervention group
Group type: COMPARATOR
Intervention: Placebo group with suction electrodes applied, producing a rhythmical massage effect
Number of subjects: 227
Study 9408935 — intervention group
Group type: COMPARATOR
Intervention: Control group with no intervention
Number of subjects: 227
Study 8214700 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (slow washout)
Number of subjects: 49
Study 8214700 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane (slow washout)
Number of subjects: 49
Study 8214700 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (fast washout)
Number of subjects: 49
Study 8214700 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane (fast washout)
Number of subjects: 49
Study 3321892 — intervention group
Group type: EXPERIMENTAL
Intervention: lidocaine/prilocaine mixture (5 g applied 90 min before testing)
Number of subjects: 116
Study 3321892 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 116
Study 11593305 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 27
Study 11593305 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 27
Study 30870668 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic strengthening intervention
Number of subjects: 1410
Study 29542045 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-pulse PASCAL-PRP treatment (SP)
Number of subjects: 52
Study 29542045 — intervention group
Group type: COMPARATOR
Intervention: Conventional PRP treatment (TP)
Number of subjects: 52
Study 29542045 — intervention group
Group type: EXPERIMENTAL
Intervention: Both SP and TP groups
Number of subjects: 52
Study 27595676 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary computed tomography angiography (CCTA)
Number of subjects: 0
Study 27595676 — intervention group
Group type: COMPARATOR
Intervention: Single photon emission computed tomography myocardial perfusion imaging (SPECT MPI)
Number of subjects: 0
Study 24493478 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based cognitive behavioral intervention (3 sessions based on IMB model)
Number of subjects: 176
Study 24493478 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational pamphlets)
Number of subjects: 176
Study 23135194 — intervention group
Group type: EXPERIMENTAL
Intervention: Supra- and subgingival scaling
Number of subjects: 100
Study 23135194 — intervention group
Group type: COMPARATOR
Intervention: Incision and drainage
Number of subjects: 100
Study 19779715 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose IL-2 + IFN (arm A, suspension)
Number of subjects: 183
Study 19779715 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic maintenance of low-dose IL-2 + IFN (arm B, maintenance)
Number of subjects: 183
Study 19779715 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy after first progression
Number of subjects: 183
Study 19779715 — intervention group
Group type: COMPARATOR
Intervention: Performance Status = 0
Number of subjects: 183
Study 19779715 — intervention group
Group type: COMPARATOR
Intervention: Female gender
Number of subjects: 183
Study 19779715 — intervention group
Group type: COMPARATOR
Intervention: Treatment arm
Number of subjects: 183
Study 21352119 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief ED‐MHL intervention (information about efficacious treatments, reputable self‐help books, and further information/services)
Number of subjects: 122
Study 21352119 — intervention group
Group type: COMPARATOR
Intervention: Control group (information about local mental health services only)
Number of subjects: 122
Study 16244021 — intervention group
Group type: EXPERIMENTAL
Intervention: Plethysmographic pulse wave amplitude (PPWA) with 15 microg of epinephrine IV
Number of subjects: 80
Study 16244021 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart rate (HR) criterion with 15 microg of epinephrine IV
Number of subjects: 80
Study 16244021 — intervention group
Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP) criterion with 15 microg of epinephrine IV
Number of subjects: 80
Study 16244021 — intervention group
Group type: COMPARATOR
Intervention: Saline IV (3 mL)
Number of subjects: 80
Study 11857606 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP/L (scaling/root planing combined with laser application)
Number of subjects: 10
Study 11857606 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP (scaling/root planing)
Number of subjects: 10
Study 11857606 — intervention group
Group type: COMPARATOR
Intervention: L (laser application)
Number of subjects: 10
Study 11857606 — intervention group
Group type: COMPARATOR
Intervention: OHI (oral hygiene instructions)
Number of subjects: 10
Study 10100441 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 119
Study 10100441 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 119
Study 10100441 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 119
Study 7538285 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost (50-150 micrograms orally administered twice a day for 10 days)
Number of subjects: 63
Study 7538285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 2184994 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 3.5 mg/kg
Number of subjects: 10
Study 2184994 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 7 mg/kg
Number of subjects: 10
Study 2184994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 36048 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic lactated saline (HLS)
Number of subjects: 0
Study 36048 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution (LRS)
Number of subjects: 0
Study 31154565 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid-containing mouthwash
Number of subjects: 29
Study 26694786 — intervention group
Group type: EXPERIMENTAL
Intervention: Miswak extract‐containing toothpaste (M‐group)
Number of subjects: 66
Study 26694786 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal toothpaste (P‐group)
Number of subjects: 66
Study 26694786 — intervention group
Group type: COMPARATOR
Intervention: Conventional toothpaste (C‐group)
Number of subjects: 66
Study 26012258 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysaccharide-rich extract of Acanthopanax senticosus (PEA)
Number of subjects: 0
Study 26012258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23859996 — intervention group
Group type: EXPERIMENTAL
Intervention: Paleo diet
Number of subjects: 13
Study 23859996 — intervention group
Group type: COMPARATOR
Intervention: American Diabetes Association (ADA) diet
Number of subjects: 13
Study 22040398 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional health promotion intervention
Number of subjects: 320
Study 22040398 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated consumer intervention
Number of subjects: 320
Study 22040398 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional health coaching
Number of subjects: 320
Study 22040398 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated consumer coaching
Number of subjects: 320
Study 22040398 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional health coaching and Activated consumer coaching
Number of subjects: 320
Study 22040398 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer activation coaching
Number of subjects: 320
Study 22040398 — intervention group
Group type: COMPARATOR
Intervention: Control group (personal development intervention)
Number of subjects: 320
Study 19135111 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart Bodies program
Number of subjects: 560
Study 19135111 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 560
Study 17762363 — intervention group
Group type: COMPARATOR
Intervention: NOHV (no prior hyperventilation)
Number of subjects: 10
Study 17762363 — intervention group
Group type: EXPERIMENTAL
Intervention: HV3% (hyperventilation to an end-tidal CO2 of 3%)
Number of subjects: 10
Study 17762363 — intervention group
Group type: EXPERIMENTAL
Intervention: HV2% (hyperventilation to an end-tidal CO2 of 2%)
Number of subjects: 10
Study 17762363 — intervention group
Group type: EXPERIMENTAL
Intervention: All conditions during standing
Number of subjects: 10
Study 17762363 — intervention group
Group type: EXPERIMENTAL
Intervention: HV2% compared to NOHV and HV3%
Number of subjects: 10
Study 17762363 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior hyperventilation
Number of subjects: 10
Study 15129391 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular NMES
Number of subjects: 61
Study 11489239 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic analyses in randomized, controlled trials (RCT)
Number of subjects: 0
Study 11489239 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic analyses in large trials
Number of subjects: 0
Study 11489239 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost‐effectiveness and cost‐utility ratios
Number of subjects: 0
Study 11489239 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality‐adjusted life year
Number of subjects: 0
Study 11489239 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost‐minimization, cost‐effectiveness, and cost‐utility analyses
Number of subjects: 0
Study 9580374 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free lidocaine 1%
Number of subjects: 59
Study 9580374 — intervention group
Group type: COMPARATOR
Intervention: Local-regional anesthesia (Control)
Number of subjects: 59
Study 7761014 — intervention group
Group type: EXPERIMENTAL
Intervention: Room air (group I)
Number of subjects: 89
Study 7761014 — intervention group
Group type: COMPARATOR
Intervention: Supplementary oxygen (group II)
Number of subjects: 89
Study 3193518 — intervention group
Group type: EXPERIMENTAL
Intervention: Castor oil
Number of subjects: 107
Study 3193518 — intervention group
Group type: EXPERIMENTAL
Intervention: X-ray preparation
Number of subjects: 107
Study 3193518 — intervention group
Group type: COMPARATOR
Intervention: Clear fluids 24 hours before the study
Number of subjects: 107
Study 29294078 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and exercises
Number of subjects: 172
Study 29294078 — intervention group
Group type: COMPARATOR
Intervention: Exercises alone
Number of subjects: 172
Study 28467572 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep dry needling (DDN)
Number of subjects: 72
Study 28467572 — intervention group
Group type: EXPERIMENTAL
Intervention: Peppering
Number of subjects: 72
Study 26213579 — intervention group
Group type: EXPERIMENTAL
Intervention: Souvenaid (active product)
Number of subjects: 212
Study 26213579 — intervention group
Group type: EXPERIMENTAL
Intervention: Souvenaid (active product) during the 24-week OLE
Number of subjects: 212
Study 26213579 — intervention group
Group type: EXPERIMENTAL
Intervention: Souvenaid (active product) continued for 24 weeks
Number of subjects: 212
Study 24147543 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-aminolevulinic acid photodynamic therapy (PDT)
Number of subjects: 40
Study 24147543 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% imiquimod cream
Number of subjects: 40
Study 24147543 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (PDT + imiquimod)
Number of subjects: 40
Study 24147543 — intervention group
Group type: EXPERIMENTAL
Intervention: PDT or imiquimod therapy (second course)
Number of subjects: 40
Study 24147543 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 40
Study 20376075 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg
Number of subjects: 141
Study 20376075 — intervention group
Group type: COMPARATOR
Intervention: Irbesartan 300 mg
Number of subjects: 141
Study 18771636 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-day famciclovir (500 mg statim, then 250 mg twice daily)
Number of subjects: 873
Study 18771636 — intervention group
Group type: COMPARATOR
Intervention: 5-day famciclovir (125 mg twice daily)
Number of subjects: 873
Study 18771636 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 873
Study 16541651 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP plus minocycline (SRP+M)
Number of subjects: 64
Study 16541651 — intervention group
Group type: COMPARATOR
Intervention: SRP (control group)
Number of subjects: 64
Study 14651726 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysteamine bitartrate
Number of subjects: 11
Study 10975175 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-trained (CT) teams
Number of subjects: 3
Study 10975175 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconfigured teams
Number of subjects: 3
Study 10975175 — intervention group
Group type: COMPARATOR
Intervention: Control teams
Number of subjects: 3
Study 9327810 — intervention group
Group type: EXPERIMENTAL
Intervention: Predetermined payment rates based on inflation-adjusted cost per visit
Number of subjects: 47
Study 9327810 — intervention group
Group type: COMPARATOR
Intervention: Conventional cost reimbursement method
Number of subjects: 47
Study 8129555 — intervention group
Group type: EXPERIMENTAL
Intervention: Myoglobin (MG)
Number of subjects: 30
Study 8129555 — intervention group
Group type: EXPERIMENTAL
Intervention: CPK and CPK-MM isoforms
Number of subjects: 30
Study 8129555 — intervention group
Group type: EXPERIMENTAL
Intervention: MM3/MM1 > 0.5
Number of subjects: 30
Study 8129555 — intervention group
Group type: EXPERIMENTAL
Intervention: CPK
Number of subjects: 30
Study 2985353 — intervention group
Group type: EXPERIMENTAL
Intervention: Low bulk dietary supplement
Number of subjects: 127
Study 2985353 — intervention group
Group type: COMPARATOR
Intervention: High bulk dietary supplement
Number of subjects: 127
Study 2985353 — intervention group
Group type: COMPARATOR
Intervention: Zinc supplement
Number of subjects: 127
Study 2985353 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study 30635932 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layer inverting closure with barbed suture
Number of subjects: 48
Study 30635932 — intervention group
Group type: COMPARATOR
Intervention: Single-layer appositional closure with barbed suture
Number of subjects: 48
Study 30635932 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layer inverting closure with nonbarbed suture
Number of subjects: 48
Study 30635932 — intervention group
Group type: COMPARATOR
Intervention: Single-layer appositional closure with nonbarbed suture
Number of subjects: 48
Study 29099344 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezacaftor (100 mg once daily) and Ivacaftor (150 mg twice daily)
Number of subjects: 510
Study 29099344 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 510
Study 26352221 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPT (Acceptance-based depression and psychosis therapy) for 4 months of outpatient treatment
Number of subjects: 13
Study 26352221 — intervention group
Group type: COMPARATOR
Intervention: Medication treatment as usual plus enhanced assessment and monitoring
Number of subjects: 13
Study 23637743 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher educational level (university vs. less than primary school)
Number of subjects: 7305
Study 23637743 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity (3rd vs. 1st tertile)
Number of subjects: 7305
Study 23637743 — intervention group
Group type: EXPERIMENTAL
Intervention: Former smoking
Number of subjects: 7305
Study 23637743 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger waist‐to‐height ratio (0.1 units increase)
Number of subjects: 7305
Study 23637743 — intervention group
Group type: EXPERIMENTAL
Intervention: Being diabetic
Number of subjects: 7305
Study 23637743 — intervention group
Group type: EXPERIMENTAL
Intervention: Being single
Number of subjects: 7305
Study 23637743 — intervention group
Group type: EXPERIMENTAL
Intervention: Being divorced or separated
Number of subjects: 7305
Study 23637743 — intervention group
Group type: EXPERIMENTAL
Intervention: Current smoking
Number of subjects: 7305
Study 21470746 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillomandibular fixation screws
Number of subjects: 0
Study 21470746 — intervention group
Group type: COMPARATOR
Intervention: Erich arch bars
Number of subjects: 0
Study 21470746 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF screws
Number of subjects: 0
Study 18562411 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride therapy
Number of subjects: 395
Study 17596167 — intervention group
Group type: EXPERIMENTAL
Intervention: becocalcidiol 75 microg g(‐1) twice daily for 8 weeks
Number of subjects: 185
Study 17596167 — intervention group
Group type: EXPERIMENTAL
Intervention: becocalcidiol 75 microg g(‐1) once daily for 8 weeks
Number of subjects: 185
Study 17596167 — intervention group
Group type: COMPARATOR
Intervention: vehicle (placebo)
Number of subjects: 185
Study 14525752 — intervention group
Group type: EXPERIMENTAL
Intervention: Test Group (TG) - students directed to see patients with specific chief complaints (CC): orthopedic injury (OR), asthma exacerbation (AE), acute coronary syndrome (ACS), traumatic injury (TR), laceration (LAC), diabetic ketoacidosis (DKA).
Number of subjects: 150
Study 14525752 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - students saw patients of their choice.
Number of subjects: 150
Study 10461500 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiosurgery
Number of subjects: 200000
Study 10461500 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggressive local therapy (surgery or radiosurgery)
Number of subjects: 200000
Study 8877267 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Grafting‐Patch Trial (CABG‐Patch)
Number of subjects: 0
Study 8877267 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicenter Automatic Implantable Defibrillator Trial (MADIT)
Number of subjects: 0
Study 8877267 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicenter Unsustained Tachycardia Trial (MUSTT)
Number of subjects: 0
Study 1830104 — intervention group
Group type: EXPERIMENTAL
Intervention: Hulka‐Clemens clip (spring-loaded clip)
Number of subjects: 365
Study 1830104 — intervention group
Group type: COMPARATOR
Intervention: Falope Ring (tubal ring)
Number of subjects: 365
Study 6604723 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g mezlocillin intramuscularly
Number of subjects: 36
Study 6604723 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g mezlocillin intramuscularly
Number of subjects: 36
Study 6604723 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 36
Study 4024002 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral high frequency oscillation (RMS input pressure 1.2 cm H2O, mean pressure zero) applied for 30 minutes alternating with 30 minutes of rest
Number of subjects: 7
Study 4024002 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral high frequency oscillation
Number of subjects: 7
Study 30312414 — intervention group
Group type: EXPERIMENTAL
Intervention: Vedolizumab
Number of subjects: 114071
Study 27280372 — intervention group
Group type: COMPARATOR
Intervention: No-questionnaire control (NQC) arm
Number of subjects: 14109
Study 27280372 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticipated regret (AR) arm
Number of subjects: 14109
Study 24916483 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B (PMX) hemoperfusion, two sessions 24 hours apart
Number of subjects: 650
Study 24916483 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 650
Study 22811471 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-h rhLH pulses
Number of subjects: 19
Study 22811471 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-h rhLH pulses
Number of subjects: 19
Study 22811471 — intervention group
Group type: COMPARATOR
Intervention: Continuous rhLH
Number of subjects: 19
Study 22811471 — intervention group
Group type: COMPARATOR
Intervention: Saline delivery
Number of subjects: 19
Study 20538225 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency specific microcurrent therapy (20 min stimulation)
Number of subjects: 35
Study 20538225 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy (control leg)
Number of subjects: 35
Study 19000394 — intervention group
Group type: EXPERIMENTAL
Intervention: Early MRI
Number of subjects: 533
Study 19000394 — intervention group
Group type: COMPARATOR
Intervention: Referral to an orthopaedic specialist without prior MRI
Number of subjects: 533
Study 15705367 — intervention group
Group type: EXPERIMENTAL
Intervention: rLH 37.5 IU
Number of subjects: 0
Study 15705367 — intervention group
Group type: EXPERIMENTAL
Intervention: rLH 75 IU
Number of subjects: 0
Study 15705367 — intervention group
Group type: COMPARATOR
Intervention: rFSH only (group A)
Number of subjects: 0
Study 15705367 — intervention group
Group type: EXPERIMENTAL
Intervention: rLH supplementation (both doses)
Number of subjects: 0
Study 12559647 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody treatment for cytomegalovirus retinitis
Number of subjects: 0
Study 12559647 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 11789259 — intervention group
Group type: EXPERIMENTAL
Intervention: Yun'an Granule (YAG)
Number of subjects: 580
Study 11789259 — intervention group
Group type: COMPARATOR
Intervention: Progesterone
Number of subjects: 580
Study 11789259 — intervention group
Group type: COMPARATOR
Intervention: Shoutai Pill
Number of subjects: 580
Study 8997929 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment Counseling (TC)
Number of subjects: 58
Study 8997929 — intervention group
Group type: COMPARATOR
Intervention: Symptom Monitoring (SM)
Number of subjects: 58
Study 1376735 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic idiopathic urticaria (CIU)
Number of subjects: 0
Study 1376735 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic idiopathic urticaria in remission (CIUR)
Number of subjects: 0
Study 1376735 — intervention group
Group type: COMPARATOR
Intervention: Normal control (NC) subjects
Number of subjects: 0
Study 6388302 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment
Number of subjects: 341
Study 6388302 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment
Number of subjects: 341
Study 6388302 — intervention group
Group type: EXPERIMENTAL
Intervention: Severity of angina
Number of subjects: 341
Study 31142269 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA colonization in middle/low SES (n = 18; 14%)
Number of subjects: 598
Study 31142269 — intervention group
Group type: EXPERIMENTAL
Intervention: MRSA strains susceptibility
Number of subjects: 598